All Projects

Funding: DFG, 45.000 EUR

Project Details:
Glycoprotein-mediated immune evasion mechanisms of human and animal pneumoviridea

Funding: DFG, 45.000 EUR

Project Details:
Role of adipose tissue as a silent reservoir for respiratory virus replication

Funding: DFG, 45.000 EUR

Project Details:
Evolution and ecology of RNA-viruses in small mammels

Funding: CEPI via Wageningen Bioveterinary Research, 1.012.106 EUR

Project Details:
A Phase I/IIa clinical trial under endemic conditions (in East African countries Uganda and Kenya) to assess the safety and immunogenicity of a rationally designed live-attenuated Rift Valley fever virus vaccine in a relevant target population.

Funding: EU Kommission (HORIZON 2020), 405.001 EUR

Project Details:
MERMAID proposes to further develop tissue-based in vitro mucosa models and assays to serve as in vitro models for
infection and to study immune protection with selected immune components. As such, the models will consist of a pathogenmucosal interface with a third dimension added, i.e. the interaction with selected immune mediators mimicking a relevant
(protective) natural immune response that can or should be obtained by vaccination. The models that will be developed will
also account for the heterogeneity existing in the population. The resultant next-generation mucosal tissue models will then
be validated using specimens derived from controlled human infection model (CHIM) studies and natural infections to
confirm the relevance of the model for the in vivo situation and the selected immune mediators. Subsequently, samples from
vaccine trials will be used to assess the induction of these immune responses in vivo and prove their efficacy ex vivo in next
generation models.

Project Details:
Infections with adenoviruses have been detected in hand-reared Common swifts in connection with stomatitis. As part of this project, the virus is to be investigated in more detail and its spread in the wild population of swifts and swallows, as possible carriers, is to be determined in the Hanover area.

Funding: DFG, 372.000 EUR

Project Details:
Der Begriff "innate immune memory" beschreibt das Phänomen, dass Zellen des angeborenen Immunsystems auf ein Pathogen oder ein Pathogen/Mikroben-assoziiertes molekulares Muster (PAMP/MAMP) anders reagieren, wenn sie vorher Kontakt mit diesem PAMP oder anderen Pathogenen hatten. Die stärkere Sekundärreaktion wird als Ausdruck eines Trainings des angeborenen Immunsystem oder als "trained innate immunity" bezeichnet, deren Induktion ein vielversprechendes prophylaktisches Konzept darstellt. Um dies für das Rind nutzbar zu machen, fehlen entscheidende Grundlagenkenntnisse über die Biologie relevanter, zu trainierender Immunzellen: die Monozyten und die aus ihnen differenzierenden Makrophagen. So ist noch unbekannt, inwieweit das hormonelle Profil und zirkulierende Stoffwechselmetaboliten von Kühen unterschiedlicher Leistungs- und Reproduktionsstadien die Monozyten/Makrophagen-Differenzierung und Polarisierung beeinflussen und wie dies das Reaktionsverhalten auf eine Stimulation mit Erreger-stämmigen Molekülen steuert und ihr innate immune training beeinflusst. Vor diesem Hintergrund soll im Projekt analysiert werden, wie sich die Zusammensetzung boviner monozytärer Subpopulationen, deren Transkriptom, das Expressionsmuster von C-Typ-Lektin-Rezeptoren (CLRs) und ihre Trainierbarkeit durch CLR-Liganden im Verlauf der Trächtigkeit und in verschiedenen Leistungsstadien verändert und gesteuert wird. Ergänzt wird dies durch mechanistische Analysen von epigenetischen Modifikationen und Effektorfunktionen myeloider Zellen nach innate immune training über CLR-Liganden. Die Analysen des CLR-vermittelten Trainings und der Monozyten/Makrophagen-Polarisierung erfolgen bei Kühen in den zentralen Lebensphasen, der Hochlaktation und der Spätträchtigkeit, um zu prüfen, wann bei der Kuh Differenzierungs-steuernde immunmodulatorische Strategien Wirksamkeit zeigen, die auf dem innate immune training-Prinzip beruhen. Im Projekt werden grundlegende Erkenntnisse über die CLR-abhängige Modulation von Monozyten- und Makrophagen-Funktionen gewonnen, die in der Prophylaxe peripartaler Infektionserkrankungen und im rationalen Design Leistungs-angepasster immunmodulatorischer Konzepte Anwendung finden können.

Funding: DFG, 498.400 EUR

Project Details:
The equine recurrent uveitis (ERU) is the main reason for blindness in horses, and 10% of the european horses are affected. Significantly, ERU is an important available model for human autoimmune uveitis as the clinical and immune-pathological characteristics are similar. As a cause for ERU, various hypotheses are described in the literature. On the one hand, infections with Leptospira interrogans are discussed as well as other bacterial, parasitic or viral infections. Independent of the initiating cause, there are numerous indications that ERU is an immune-mediated disease. In the body after the control of the primary infection, an overreaction of the immune system occurs in response to activated immune cells. In addition to lymphocytes, these immune cells can also be neutrophil granulocytes. Among various antimicrobial functions, neutrophils have been shown to release neutrophil extracellular traps (NETs). NETs are extracellular DNA fibers with associated proteases and antimicrobial peptides which are released by activated cells. NETs mediate entrap of invading pathogens, but when massively released may contribute to detrimental autoimmune reactions of the host.
The research project presented here is intended to provide essential insights for the involvement of NETs in the pathogenesis of ERU. In the first phase of our study, our findings indicate an involvement of NETs in the pathogenesis of ERU with detrimental effects. In short, NETs correlate to disease severity, seem to damage the blood retinal cells, and induce autoantibodies against NET proteins. We hypothesize, that those autoantibodies might shield the NETs from degradation by DNases, resulting in their persistence and potentially in new disease episodes. Thus, in the current project we aim to characterize if and how the phase of disease (non-active quiescent phase versus acute inflammatory phase) influences cellular involvement and extracellular DNA release. Based on our previous data, we further hypothesize that different cell types besides neutrophils play a role in extracellular DNA release during the progression of ERU, which enables crosstalk between various immune cells. Therefore, we will study the release of ETs by other immune cells besides neutrophils and its interplay with adaptive immune cells. Finally, since the use of gentamicin in the treatment of ERU patients is well established, the aim is to determine the influence of gentamicin in varying concentrations and along with distinct stimuli on equine immune cells, focusing on ET release.
 

Funding: Niedersächsisches Ministerium für Wissenschaft und Kultur (MWK), 324.000 EUR

Project Details:
The aim of this subproject is the further development and optimization of a 3D lung epithelial cell culture model
for the investigation of viral and bacterial infections and the effect of immunomodulatory
immunomodulatory substances on the course of infection and cell biochemical processes. An increased
complexity of the model system using physiological or pathophysiological oxygen
conditions and microfluidic systems enables the in vitro system to be approximated to the in vivo situation and
to the in vivo situation and will help to reduce the number of test animals in the long term. The
complexity of the infection model is reduced by physiologically relevant oxygen conditions (defined
tissue-specific hypoxic conditions) and by 3D co-cultivation of human or animal pulmonary
or animal pulmonary epithelial cells and neutrophil granulocytes. In addition
the use of primary cells and induced pluripotent stem cells should provide long-term optimization.

Funding: Bundesministerium für Bildung und Forschung, 625.000 EUR

Project Details:
As long as animal experiments cannot be completely replaced, the question will arise on which animals research should take place. In this project, an interdisciplinary working group wants to investigate the ELSA-relevant question, according to which criteria the selection of laboratory animal models takes place or should take place. The aim of the enterprise is to determine the manifold reasons for the choice of certain laboratory animals; the process is interdisciplinary in the full sense of the word and put the different rationalities into a well-founded correlation. The question condenses several open and important issues concerning the treatment of animals. The answer is to be examined in each of the disciplines involved, between them and finally in their association, whether it is possible to establish a coherent catalog of criteria that also creates clarity for the practice of animal experimentation, both for everyday research and at the interface to legislation and enforcement. This is important against the background of rapidly changing social value judgements about animals, which also lead to permanent tensions here. In this project we want to investigate the ELSA-relevant question of the criteria for the selection of laboratory animal models. We follow an interdisciplinary approach, which is represented by the following cooperation partners: Its members are: Prof. Dr. Peter Kunzmann (ethics), Prof. Dr. Bernhard Hiebl (laboratory animal science), Prof. Dr. Maren von Köckritz-Blickwede (infection research) (all TiHo- Hannover) and the legal scientist Prof. Dr. Dr. Tade Spranger (University of Bonn).

Cooperation Partners:

Tade Spranger, Rechts- und Staatswissenschaftliche Fakultät, Bonn